Therefore, CSA patients with microcytic anemia, in whom mutations of ALAS2 gene were not identified, were expected to harbor SLC25A38 mutation; however, it was not detectable in this study. This evidence concerns the gene SLC25A38 and chromosome-type aberration frequency.